BamSEC and AlphaSense Join Forces
Learn More

LogicBio Therapeutics, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 61 pages Article 1 Definitions
12/34/56
EX-10.1
from 8-K 10 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That LogicBio Therapeutics, Inc. Treats as Private or Confidential Amendment No. 8 To
12/34/56
EX-10.2
from 10-Q 16 pages LogicBio Therapeutics, Inc. Confidential Information, Invention Assignment, Restricted Activities, and Arbitration Agreement
12/34/56
EX-10.1
from 10-Q 10 pages LogicBio Therapeutics, Inc. Executive Employment Agreement
12/34/56
EX-10.8
from 10-K 4 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That LogicBio Therapeutics, Inc. Treats as Private or Confidential Amendment No. 7 To
12/34/56
EX-10.2
from 10-Q 3 pages LogicBio Therapeutics, Inc. Inducement Award Agreement
12/34/56
EX-10.1
from 10-Q 13 pages Indemnification Agreement
12/34/56
EX-10.8
from 10-Q 4 pages Restricted Stock Unit Agreement
12/34/56
EX-10.7
from 10-Q 16 pages LogicBio Therapeutics, Inc. Confidential Information, Invention Assignment, Restricted Activities, and Arbitration Agreement
12/34/56
EX-10.6
from 10-Q 13 pages LogicBio Therapeutics, Inc. At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement
12/34/56
EX-10.5
from 10-Q 7 pages Consultancy Agreement
12/34/56
EX-10.4
from 10-Q 8 pages Consultancy Agreement
12/34/56
EX-10.3
from 10-Q ~1 page Frederic Chereau, Chief Executive Officer Agreed to and Accepted By: Signature: /S/Kyle Chiang Name (Print): Kyle Chiang Date: 11/6/2020 CC: Personnel File
12/34/56
EX-10.2
from 10-Q 11 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 94 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.1
from 10-Q 4 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That LogicBio Therapeutics, Inc. Terats as Private or Confidential Amendment No. 6 to Amended and Restated Exclusive (Equity) Agreement
12/34/56
EX-10.22
from 10-K 11 pages LogicBio Therapeutics, Inc. Executive Employment Agreement
12/34/56
EX-10.6
from 10-K 4 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That LogicBio Therapeutics, Inc. Treats as Private or Confidential Amendment No. 5 to Amended and Restated Exclusive (Equity) Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to LogicBio Therapeutics, Inc. if Publicly Disclosed Amendment No. 2 to Patent & Technology License Agreement
12/34/56